George S. Barrett | |
---|---|
Nationality | American |
Alma mater | Brown University, New York University |
Occupation | Executive Chairman |
Organization | Cardinal Health, Inc. |
George S. Barrett is an American business executive in the health care industry. He served as chairman and chief executive officer of Cardinal Health, Inc. from 2009 to 2017. [1] He joined the board of the Columbus Foundation in December 2017. [2]
Hi
Born to Lucille and Herbert Barrett,[ when? ] George Barrett was one of five children. He attended Westport, Connecticut's Staples High School. [3] Barrett received his Bachelor of Arts degree from Brown University and his M.B.A. from New York University. [4] He also holds an honorary Doctor of Humane Letters degree from Long Island University's Arnold and Marie Schwartz College of Pharmacy and Health Sciences. [5]
After college, Barrett worked as a teacher in private schools and pursued a music career. He served as president of NMC Laboratories until it was acquired by Alpharma in 1990. Before earning his master's degree, he worked at a small dermatology firm, which he eventually ran. Barrett was president of US Pharmaceuticals from 1994 until 1997. [6] In 1999, he joined Teva Pharmaceutical Industries Ltd. [7] as president of Teva USA. In 2005, he became CEO and president of North America for Teva. In addition, he became Corporate Executive Vice President for Global Pharmaceutical Markets in 2007. [6]
In 2008, Barrett joined Cardinal Health, Inc. as vice chairman and CEO of Healthcare Supply Chain Services. [3] He became the chairman and chief executive officer of the company in 2009. [3] [8] As of September 2016, Barrett is reported to own over 0.5 million of Cardinal Health shares worth of approximately US$42 million.
Barrett was named a trustee at The Conference Board, Inc. in 2010. He became an independent director of Eaton Corporation in 2011. He is on the board of trustees of the Healthcare Leadership Council and The Conference Board. He serves on the board of directors for Nationwide Children's Hospital Inc. He is also a member of the President's Leadership Council of Brown University. He is a member of the Business Roundtable, The Business Council, the Columbus Partnership, and Ohio Business Roundtable. [9]
Barrett is a musician and performed in October 2014, at Cardinal Health's Retail Business Conference in Washington, D.C., with his band. In 2023, Barrett released an album of original music written and performed by Barrett, entitled "Not Alone." Barrett supports pediatric cancer programs at Nationwide Children's Hospital. [10]
Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
Robert D. Walter is an American businessman best known for his role in the creation of Cardinal Health.
Bruce Downey is the former chairman and CEO of Barr Pharmaceuticals and in 2009 became a partner at New Spring Capital, a venture capital firm.
Ronald Allen Williams is an American businessman and board director on corporate, public sector and non-profit boards. Williams is the author of Learning to Lead: The Journey to Leading Yourself, Leading Others, and Leading an Organization, which appeared on The Wall Street Journal's best seller list. He is founder, chairman and CEO of RW2 Enterprises, LLC. Williams is the former chairman, president and chief executive officer (CEO) of Aetna Inc.. Aetna is now part of CVS Health.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (API's) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Paul M. Montrone is the Chairman, President, and CEO of Perspecta Trust LLC, Liberty Lane Partners and Latona Associates. Montrone was the Chairman and CEO of Fisher Scientific until its 2006 merger with Thermo Electron.
Phillip Frost is an American entrepreneur.
Jeremy Levin is a South African-born businessman, medical doctor and research scientist. In 2018, Levin was named as one of the most influential figures in the biopharmaceutical industry.
José E. Almeida is a Brazilian businessman. He has served as the chairman and CEO of Baxter International, Inc. since January 2016. He worked for Tyco Healthcare from 1995 to 2002. He was president of Medical Devices division from October 2006 to June 2011. He served as chairman of the board of directors of Covidien since March 2012 and as the president, chief executive officer and a director since July 2011. He became a director of EMC Corporation on Jan 12, 2015 and resigned on October 30, 2015, due to his election as chairman and CEO of Baxter. In 2015, he worked for The Carlyle Group as an Operating Executive in the Global Healthcare group.
Alex Gorsky is an American businessman. He is the former chairman and CEO of Johnson & Johnson. Gorsky stepped down as CEO of Johnson & Johnson in January 2022 and was succeeded by Joaquin Duato. He was the seventh person who served as the company's chairman and chief executive officer since it became a publicly traded company in 1944. He is a board director of Apple and JP Morgan Chase.
John C. Lechleiter is an American businessman and chemist. He served as president, chief executive officer, and chairman of the board of directors of Eli Lilly and Company from April 2008 to December 2016.
Chris Viehbacher is a German-Canadian businessman. He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014. Viehbacher then worked with Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family.
Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.
Bruce Dale Broussard is an American business executive. From 2013 to 2024, Broussard served as Chief Executive Officer of Humana, a healthcare company with headquarters in Louisville, Kentucky. Prior to joining Humana, he served in several executive roles, including chief executive office of McKesson Specialty/US Oncology.
Stefan Oschmann is a German businessman. He was the CEO of pharma group Merck.
Joseph C. Papa is an American businessman and the chairman and chief executive officer (CEO) of Bausch & Lomb, a company formed from the initial public offering (IPO) of the eye health business of Bausch Health Companies Inc.
Dr. Harold L. Paz is the former executive vice president of health sciences at Stony Brook University and former chief executive officer of Stony Brook University Medicine. He is the former executive vice president and chancellor for health affairs at Ohio State University and chief executive officer of the Ohio State Wexner Medical Center. Prior to that, he served as executive vice president and chief medical officer at CVS Health/Aetna.
Kåre Schultz is a Danish business executive. Was the chief executive officer of Teva Pharmaceutical Industries between September 2017 - December 2022.
Albert Bourla is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla was chief operating officer.
Brent Saunders is an American biopharma executive and entrepreneur who is the chairman and CEO of the health company Bausch & Lomb. He helped lead various mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America.